PharmaCyte Biotech (PMCB) Return on Sales (2010 - 2013)
PharmaCyte Biotech (PMCB) posted quarterly Return on Sales of 4.18% for Q3 2013, down 330.0% year-over-year from 1.82% in Q3 2012, and down 199.62% quarter-over-quarter from 1.39% in Q2 2013.
PharmaCyte Biotech (PMCB) Return on Sales (2010 - 2013) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Return on Sales for 4 consecutive years, with 4.18% the latest figure, recorded in Q3 2013.
- In Q3 2013, Return on Sales fell 330.0% year-over-year to 4.18%; the TTM figure through Jul 2013 stood at 4.18% (down 379.0% YoY), while the FY2013 annual figure was 11.63%, down 1130.0% from the prior year.
- Return on Sales slipped to 4.18% in Q3 2013 per PMCB's latest filing, from 1.39% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q4 2010 and bottomed at 4.18% in Q3 2013.
- Historically, Return on Sales has averaged 0.76% across 4 years, with a median of 0.35% in 2011.
- Annual changes were most pronounced in 2011 — Return on Sales decreased 22 bps — and 2013, when it tumbled 330 bps.
- PharmaCyte Biotech's Return on Sales stood at 0.0% in 2010, then plunged by 4784 bps to 0.22% in 2011, then slumped by 200 bps to 0.66% in 2012, then plunged by 531 bps to 4.18% in 2013.
- Business Quant data shows PMCB's Return on Sales at 4.18% in Q3 2013, 1.39% in Q2 2013, and 1.0% in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2013 | -4.18% |
| Apr 30, 2013 | -1.39% |
| Jan 31, 2013 | -1.00% |
| Oct 31, 2012 | -0.66% |
| Jul 31, 2012 | -0.88% |
| Apr 30, 2012 | -0.91% |
| Jan 31, 2012 | -0.22% |
| Oct 31, 2011 | -0.22% |
| Jul 31, 2011 | -0.35% |
| Apr 30, 2011 | -0.10% |
| Jan 31, 2011 | 0.00% |
| Oct 31, 2010 | 0.00% |
| Jul 31, 2010 | -0.01% |